SAA is an acute-phase protein associated with inflammation, and hence it is unlikely to be PCa specific but, in conjunction with other PCa biomarkers, could be a useful addition to a panel of (companion) biomarkers. The gene discussed is SAA1; the disease is posterior cortical atrophy.